XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance, shares at Dec. 31, 2021     701,780 15,497        
Balance, amount at Dec. 31, 2021 $ 4,379,463 $ 0 $ 702 $ (816,707) $ 39,692,595 $ 0 $ (34,345,506) $ (151,621)
Foreign currency translation adjustment, net (405,229) $ 0 0 0 0 0 0 (405,229)
Issuance of Series A preferred stock, net of issuance costs of $547,700, shares   6,000            
Issuance of Series A preferred stock, net of issuance costs of $547,700, amount 0 $ 5,452,300 $ 0 0 0 0 0 0
Conversion of notes payable into shares of common stock, shares     9,520          
Conversion of notes payable into shares of common stock, amount 973,420 0 $ 10 0 973,410 0 0 0
Cashless exercise of warrants, shares     33,179          
Cashless exercise of warrants, amount 0 0 $ 33 0 (829) 0 0 0
Net income 203,347 $ 0 $ 0 $ 0 0 0 203,347 0
Balance, shares at Mar. 31, 2022   6,000 744,479 15,497        
Balance, amount at Mar. 31, 2022 5,151,001 $ 5,452,300 $ 745 $ (816,707) 40,665,176 0 (34,142,159) (556,850)
Balance, shares at Dec. 31, 2022     10,605,412 15,497        
Balance, amount at Dec. 31, 2022 39,284,295 372,414 $ 10,606 $ (816,707) 112,205,952 (4,750,108) (66,232,813) (1,132,635)
Foreign currency translation adjustment, net 336,463 0 0 0 0 0 0 336,463
Net income (459,863) 0 0 0 0 0 (459,863) 0
Proceeds from sale of common stock 4,750,000 0 $ 0 0 0 4,750,000 0 0
Shares issued in lieu of cash, shares     15,258          
Shares issued in lieu of cash, amount 96,888 0 $ 15 $ 0 96,873 0 0 0
Balance, shares at Mar. 31, 2023     10,620,670 15,497        
Balance, amount at Mar. 31, 2023 $ 44,007,783 $ 372,414 $ 10,621 $ (816,707) $ 112,302,825 $ (108) $ (66,692,676) $ (796,172)